Shopping Cart
Remove All
Your shopping cart is currently empty
HRS 4642 is a long-acting, selective KRAS G12D inhibitor with a Kd value of 0.083 nM. It inhibits phosphorylation of downstream MEK and ERK proteins, exhibiting antitumour activity. HRS 4642 reduces target lesions and, when used alone or in combination with Carfilzomib, remodels the tumour microenvironment towards an immunocompetent state.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $243 | - | In Stock | |
| 2 mg | $283 | - | In Stock | |
| 5 mg | $347 | - | In Stock | |
| 10 mg | $553 | - | In Stock | |
| 25 mg | $1,090 | - | In Stock | |
| 50 mg | $1,770 | - | In Stock | |
| 100 mg | $2,830 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $483 | - | In Stock |
| Description | HRS 4642 is a long-acting, selective KRAS G12D inhibitor with a Kd value of 0.083 nM. It inhibits phosphorylation of downstream MEK and ERK proteins, exhibiting antitumour activity. HRS 4642 reduces target lesions and, when used alone or in combination with Carfilzomib, remodels the tumour microenvironment towards an immunocompetent state. |
| Targets&IC50 | KRas (G12D):0.083 nM (Ki) |
| Synonyms | HRS-4642, HRS4642 |
| Molecular Weight | 632.68 |
| Formula | C34H35F3N6O3 |
| Cas No. | 2836263-09-1 |
| Smiles | C(OC=1N=C2C3=C(N1)C(F)=C(N=C3OC[C@]4(N2C[C@@]5(N[C@]4(CC5)[H])[H])[H])C=6C7=C(C=CC(F)=C7CC)C=C(O)C6)[C@@]89N(C[C@H](F)C8)CCC9 |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: ≥ 80 mg/mL, Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (7.9 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.